QAISER T, MUKHERJEE A, REDDY PB C, MUNUGOTI SD, TALLAM V, PITKÄAHO T, LEHTIMÄKI T, NAUGHTON T, BERSETH M, PEDRAZA A, MUKUNDAN R, SMITH M, BHALERAO A, RODNER E, SIMON M, DENZLER J, HUANG CH, BUENO G, SNEAD D, ELLIS IO, ILYAS M and RAJPOOT N, 2018. Her2 Challenge Contest: A Detailed Assessment of Automated Her2 Scoring Algorithms in Whole Slide Images of Breast Cancer Tissues. Histopathology. 72(2), 227-238 RAPOSO TP, EBILI HO and ILYAS M, 2017. A refined method to study gene dosage changes in vitro using CRISPR/Cas9. Journal of clinical pathology. (In Press.)
EBILI HO, HASSALL JC, FADHIL W, HAM-KARIM H, ASIRI A, RAPOSO TP, AGBOOLA AJ and ILYAS M, 2017. "Squirrel" Primer-Based PCR Assay for Direct and Targeted Sanger Sequencing of Short Genomic Segments. Journal of biomolecular techniques : JBT. (In Press.)
EBILI HO, HASSALL J, ASIRI A, HAM-KARIM H, FADHIL W, AGBOOLA AJ and ILYAS M, 2017. QMC-PCRx: a novel method for rapid mutation detection. Journal of clinical pathology. 70(8), 702-711 THORPE H, AKHLAQ M, JACKSON D, AL GHAMDI S, STORR S, MARTIN S and ILYAS M, 2016. Multiple pathways regulate Cten in colorectal cancer without a Tensin switch. International journal of experimental pathology. 96(6), 362-9 KAYE PV, ILYAS M, SOOMRO I, HAIDER SA, ATWAL G, MENON S, GILL S, RICHARDS C, HARRISON R, WEST K and RAGUNATH K, 2016. Dysplasia in Barrett's oesophagus: p53 immunostaining is more reproducible than haematoxylin and eosin diagnosis and improves overall reliability, while grading is poorly reproducible. Histopathology. 69(3), 431-40 KAEWKANGSADAN V, VERMA C, EREMIN JM, COWLEY G, ILYAS M and EREMIN O, 2016. Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer. Journal of immunology research. 2016, 4757405 MCGREGOR MJ, FADHIL W, WHARTON R, YANAGISAWA Y, PRESZ M, PRITCHARD A, WOMACK C, DUTTON S, KERR RS, KERR DJ, JOHNSTONE EC and ILYAS M, 2015. Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trial. Anticancer research. 35(3), 1641-5
ALBASRI A, FADHIL W, SCHOLEFIELD JH, DURRANT LG and ILYAS M, 2014. Nuclear expression of phosphorylated focal adhesion kinase is associated with poor prognosis in human colorectal cancer. Anticancer research. 34(8), 3969-74
WONG NA, GONZALEZ D, SALTO-TELLEZ M, BUTLER R, DIAZ-CANO SJ, ILYAS M, NEWMAN W, SHAW E, TANIERE P, WALSH SV and , 2014. RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group. Journal of clinical pathology. 67(9), 751-7 IBRAHEM S, AL-GHAMDI S, BALOCH K, MUHAMMAD B, FADHIL W, JACKSON D, NATERI AS and ILYAS M, 2014. STAT3 paradoxically stimulates β-catenin expression but inhibits β-catenin function. International journal of experimental pathology. 95(6), 392-400 FADHIL, WAKKAS, KINDLE, KARIN, JACKSON, DARRYL, ZAITOUN, ABED, LANE, NINA, ROBINS, ADRIAN and ILYAS, MOHAMMAD, 2014. DNA content analysis of colorectal cancer defines a distinct 'microsatellite and chromosome stable' group but does not predict response to radiotherapy INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. 95(1), 16-23 ILYAS, MOHAMMAD, 2014. MOLECULAR BIOLOGY OF COLORECTAL CANCER: LIFE AFTER NGS! ANTICANCER RESEARCH. 34(10), 5961-5962
IBRAHEM, SALIH, AL-GHAMDI, SALEH, BALOCH, KANWAL, MUHAMMAD, BELAL, FADHIL, WAKKAS, JACKSON, DARRYL, NATERI, ABDOLRAHMAN S. and ILYAS, MOHAMMAD, 2014. STAT3 paradoxically stimulates beta-catenin expression but inhibits beta-catenin function INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. 95(6), 392-400 THORPE, H., AL-GHAMDI, S. and ILYAS, M., 2014. The regulation of Cten in colorectal cancer VIRCHOWS ARCHIV. 465, S11-S11
ZAITOUN, A., MUKERJEE, A., ABBAS, A., WILLIAMS, J. and ILYAS, M., 2014. Improvement in stage and prognostic parameters in colorectal cancer in the post-screening era: a single institution study VIRCHOWS ARCHIV. 465, S222-S222
ILYAS, M., KARIM, H., CROSS, G. and MANGER, K., 2014. Comparison of Chromosomal Instability (CIN) and Microsatellite and Chromosome Stability (MACS) using targeted next generation sequencing VIRCHOWS ARCHIV. 465, S238-S238
OTIFI, H. and ILYAS, M., 2014. Investigating the biological role of CD24 in the development of colorectal cancer VIRCHOWS ARCHIV. 465, S323-S323
THORPE, H., AKHLAQ, M. and ILYAS, M., 2014. Nuclear Cten as a regulator of cancer cell stemness VIRCHOWS ARCHIV. 465, S323-S324
AKHLAQ, M. and ILYAS, M., 2014. The role of tyrosine phosphorylation in regulating Cten function VIRCHOWS ARCHIV. 465, S325-S325
AKHLAQ, M., MARTIN, S. and ILYAS, M., 2014. Regulation of Cten levels by Calpains VIRCHOWS ARCHIV. 465, S326-S326
ALMASMOUM, H., FADHIL, W., JACKSON, D. and ILYAS, M., 2014. Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 functions as an oncogene that promotes proliferation migration and invasion in colorectal cancer VIRCHOWS ARCHIV. 465, S328-S328
ALMASMOUM, H., FADHIL, W., JACKSON, D. and ILYAS, M., 2014. Protein tyrosine phosphatase, non-receptor type 1 gene functions as an oncogene and promotes cell motility in colorectal cancer VIRCHOWS ARCHIV. 465, S328-S329
AL-GHAMDI S, CACHAT J, ALBASRI A, AHMED M, JACKSON D, ZAITOUN A, GUPPY N, OTTO WR, ALISON MR, KINDLE KB and ILYAS M, 2013. C-terminal tensin-like gene functions as an oncogene and promotes cell motility in pancreatic cancer. Pancreas. 42(1), 135-40 IBRAHIM, E.E., BABAEI-JADIDI, R., SAADEDDIN, A., SPENCER-DENE, B., HOSSAINI, S., ABUZINADAH, M., LI, N., FADHIL, W., ILYAS, M., BONNET, D. and NATERI, A.S., 2012. Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms Stem Cells. 30(10), 2076-2087 BEGGS AD, DOMINGO E, MCGREGOR M, PRESZ M, JOHNSTONE E, MIDGLEY R, KERR D, OUKRIF D, NOVELLI M, ABULAFI M, HODGSON SV, FADHIL W, ILYAS M and TOMLINSON IPM, 2012. Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN. Oncotarget. 3(11), 1348-55
SALEH AL-GHAMDI and MOHAMMAD ILYAS, 2012. TNS4 (tensin 4) Atlas Genet Cytogenet Oncol Haematol.. Available at: <http://AtlasGeneticsOncology.org/Genes/TNS4ID40190ch17q21.html> ADAMS, GARY G, KOK, M SAMIL, IMRAN, SHAHWAR, HARDING, STEPHEN E, ILYAS, MOHAMMAD and TATHAM, ARTHUR S, 2012. The interaction of dietary fibres with disulphide bonds (S-S) and a potential strategy to reduce the toxicity of the gluten proteins in coeliac disease. Biotechnology & genetic engineering reviews. 28, 115-30 AL-GHAMDI, S., ALBASRI, A., CACHAT, J., IBRAHEM, S., MUHAMMAD, B.A., JACKSON, D., NATERI, A.S., KINDLE, K.B. and ILYAS, M., 2011. Cten is targeted by Kras signalling to regulate cell motility in the colon and pancreas PloS One. 6(6), e20919 AHMED MAH, ALESKANDARANY MA, RAKHA EA, MOUSTAFA RZA, BENHASOUNA A, NOLAN C, GREEN AR, ILYAS M and ELLIS IO, 2011. A Cd44(-)/Cd24 (+) Phenotype Is A Poor Prognostic Marker In Early Invasive Breast Cancer. Breast Cancer Research And Treatment. (In Press.)
ALBASRI, A., AL-GHAMDI, S., FADHIL, W., ALESKANDARANY, M., LIAO, Y.-C., JACKSON, D., LOBO, D.N., LO, S.H., KUMARI, R., DURRANT, L., WATSON, S., KINDLE, K.B. and ILYAS, M., 2011. Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer Oncogene. 30(26), 2997-3002 JACKSON, T, AHMED, MAH, SETH, R, JACKSON, D and ILYAS, M, 2011. Mlh1 Function Is Context Dependent In Colorectal Cancers Journal Of Clinical Pathology. 64(2), 141-145 ALBASRI, A, ALESKANDARANY, M, BENHASOUNA, A, POWE, DG, ELLIS, IO, ILYAS, M and GREEN, AR, 2011. Cten (C-Terminal Tensin-Like), A Novel Oncogene Overexpressed In Invasive Breast Carcinoma Of Poor Prognosis Breast Cancer Research And Treatment. 126(1), 47-54 AHMED, MOHAMED A H, JACKSON, DARRYL, SETH, RASHMI, ROBINS, ADRIAN, LOBO, DILEEP N, TOMLINSON, IAN P M and ILYAS, MOHAMMAD, 2010. CD24 is upregulated in inflammatory bowel disease and stimulates cell motility and colony formation. Inflammatory bowel diseases. 16(5), 795-803 ALOYSIUS, MARK M, ZAITOUN, ABED M, BATES, TIMOTHY E, ILYAS, MOHAMMAD, CONSTANTIN-TEODOSIU, DUMITRU, ROWLANDS, BRIAN J and LOBO, DILEEP N, 2010. Immunohistochemical expression of mitochondrial membrane complexes (MMCs) I, III, IV and V in malignant and benign periampullary epithelium: a potential target for drug therapy of periampullary cancer? BMC Cancer. 10(1), 80
ALOYSIUS, M.M., ZAITOUN, A.M., AWAD, S., ILYAS, M., ROWLANDS, B.J. and LOBO, D.N., 2010. Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer British Journal of Surgery. 97(8), 1269-1278 ELSABA, TAREK M A, MARTINEZ-POMARES, LUISA, ROBINS, ADRIAN R, CROOK, SIMON, SETH, RASHMI, JACKSON, DARRYL, MCCART, AMY, SILVER, ANDREW R, TOMLINSON, IAN P M and ILYAS, MOHAMMAD, 2010. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PloS one. 5(5), e10714 SIMPSON, J.A.D., AL-ATTAR, A., WATSON, N.F.S., SCHOLEFIELD, J.H., ILYAS, M. and DURRANT, L.G., 2010. Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer Gut. 59(7), 926-933 KAYE PV, HAIDER SA, JAMES PD, SOOMRO I, CATTON J, PARSONS SL, RAGUNATH K and ILYAS M, 2010. Novel Staining Pattern Of P53 In Barrett's Dysplasia--The Absent Pattern. Histopathology. 57(6), 933-5 TEJPAR S, BERTAGNOLLI M, BOSMAN F, LENZ H, GARRAWAY L, WALDMAN F, WARREN R, BILD A, COLLINS-BRENNAN D, HAHN H, HARKIN DP, KENNEDY R, ILYAS M, MORREAU H, PROUTSKI V, SWANTON C, TOMLINSON I, DELORENZI M, FIOCCA R, VAN CUTSEM E and ROTH A, 2010. Prognostic And Predictive Biomarkers In Resected Colon Cancer: Current Status And Future Perspectives For Integrating Genomics Into Biomarker Discovery. The Oncologist. 15(4), 390-404 KAYE, PV, HAIDER, SA, JAMES, PD, SOOMRO, I, CATTON, J, PARSONS, SL, RAGUNATH, K and ILYAS, M, 2010. Novel Staining Pattern Of P53 In Barrett's Dysplasia - The Absent Pattern IBRAHEM, S, SETH, R, O'SULLIVAN, B, FADHIL, W, TANIERE, P and ILYAS, M, 2010. Comparative Analysis Of Pyrosequencing And Qmc-Pcr In Conjunction With High Resolution Melting For Kras/Braf Mutation Detection International Journal Of Experimental Pathology. 91(6), 500-505 ALBASRI, A., SETH, R., JACKSON, D., BENHASOUNA, A., CROOK, S., NATERI, A.S., CHAPMAN, R. and ILYAS, M., 2009. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer The Journal of pathology: a journal of the Pathological Society of Great Britain and Ireland. 218(1), 57-65 ALOYSIUS, MARK M, LOBO, DILEEP N, ROWLANDS, BRIAN J, MADHUSUDAN, SREENIVASAN, ILYAS, MOHAMMAD and ZAITOUN, ABED M, 2009. HER-2/Neu overexpression is a rare event in peri-ampullary cancer: assessment using the HercepTest. Histopathology. 55(2), 236-7
AHMED MAH, AL-ATTAR A, KIM J, WATSON NFS, SCHOLEFIELD JH, DURRANT LG and ILYAS M, 2009. Cd24 Shows Early Upregulation And Nuclear Expression But Is Not A Prognostic Marker In Colorectal Cancer. Journal Of Clinical Pathology. 62(12), 1117-22 SETH, R., CROOK, S., IBRAHEM, S., FADHIL, W., JACKSON, D. and ILYAS, M., 2009. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer Gut. 58(9), 1234-1241 KAYE PV, HAIDER SA, ILYAS M, JAMES PD, SOOMRO I, FAISAL W, CATTON J, PARSONS SL and RAGUNATH K, 2009. Barrett's Dysplasia And The Vienna Classification: Reproducibility, Prediction Of Progression And Impact Of Consensus Reporting And P53 Immunohistochemistry. Histopathology. 54(6), 699-712 ELAHI E, SURAWEERA N, VOLIKOS E, HAINES J, BROWN N, DAVIDSON G, CHURCHMAN M, ILYAS M, TOMLINSON I and SILVER A, 2009. Five Quantitative Trait Loci Control Radiation-Induced Adenoma Multiplicity In Mom1r Apc Min/+ Mice. Plos One. 4(2), e4388 THURLEY PD, HALLIDAY KE, SOMERS JM, AL-DARAJI WI, ILYAS M and BRODERICK NJ, 2009. Radiological features of meckel's diverticulum and its complications. Clinical radiology. 64(2), 109-18 NAIK,, PATIL,, SCHOLEFIELD,, KAYE,, JAMES,, ILYAS, and ZAITOUN,, 2008. Adenocarcinoma arising in a background of chronic atrophic pouchitis in an ileoanal pouch for ulcerative colitis. Histopathology.
SEGDITSAS, S., SIEBE, O., DEHERAGODA, M., EAST, P., ROWAN, A., JEFFERY, R., NYE, E., CLARK, S., SPENCER-DENE, B., STAMP, G., POULSOM, R., SURAWEERA, N., SILVER, A., ILYAS, M. and TOMLINSON, I., 2008. Putative direct and indirect wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice Human Molecular Genetics. 17(24), 3864-3875 VAN LEEUWEN, I.M.M., EDWARDS, C.M., ILYAS, M. and BYRNE, H.M., 2007. Towards a multiscale model of colorectal cancer. World Journal of Gastroenterology. 13(9), 1399-407
ILYAS, M., 2007. Wnt Signal Transduction. In: ALISON, M.R., HALL, P.A., GOODERHAM, N.J., WEISS, L.M., HAIER, J., LEMOINE, N.R. and TEMPERO, M.A., eds., The Cancer Handbook 2nd ed. John Wiley and Sons. 242-256
PATEL, HEENA, POLANCO-ECHEVERRY, GUADALUPE, SEGDITSAS, STEFANIA, VOLIKOS, EMMANOUIL, MCCART, AMY, LAI, CECILIA, GUENTHER, THOMAS, ZAITOUN, ABED, SIEBER, OLIVER, ILYAS, MOHAMMED, NORTHOVER, JOHN and SILVE, 2007. Activation of AKT and nuclear accumulation of wild type TP53 and MDM2 in anal squamous cell carcinoma. International journal of cancer. Journal international du cancer. 121(12), 2668-73
MARTINEZ, C., BHATTACHARYA, S., FREEMAN, T., CHURCHMAN, M. and ILYAS, M., 2005. Expression profiling of murine intestinal adenomas reveals early deregulation of multiple matrix metalloproteinase (Mmp) genes Journal of Pathology. 206(1), 100-110 HAINES, J., JOHNSON, V., PACK, K., SURAWEERA, N., SLIJEPCEVIC, P., CABUY, E., COSTER, M., ILYAS, M., WILDING, J., SIEBER, O., BODMER, W., TOMLINSON, I. and SILVER, A., 2005. Genetic basis of variation in adenoma multiplicity in ApcMin/+Mom1S mice Proceedings of the National Academy of Sciences of the United States of America. 102(8), 2868-2873 KEMP, ZOE, ROWAN, ANDREW, CHAMBERS, WILLIAM, WORTHAM, NOEL, HALFORD, SARAH, SIEBER, OLIVER, MORTENSEN, NEIL, VON HERBAY, AXEL, GUNTHER, THOMAS, ILYAS, MOHAMMAD and TOMLINSON, IAN, 2005. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability. Cancer Research. 65(24), 11361-6 ILYAS, M., 2005. The Molecular Biology of Cancer. In: ARNOLD,R., MALFERTHEINER, P. and GOUMA, D.J., eds., Gastroinestinal Oncology and Innovative Aspects in Gastroenterology John Libbey Eurotext. 5-11
SIEBER, O.M., HOWARTH, K.M., THIRLWELL, C., ROWAN, A., MANDIR, N., GOODLAD, R.A., GILKAR, A., SPENCER-DENE, B., STAMP, G., JOHNSON, V., SILVER, A., YANG, H., MILLER, J.H., ILYAS, M. and TOMLINSON, I.P.M., 2004. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice Cancer Research. 64(24), 8876-8881 WILDING, J., STRAUB, J., BEE, J., CHURCHMAN, M., BODMER, W., DICKSON, C., TOMLINSON, I. and ILYAS, M., 2002. Cyclin D1 Is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice Cancer Research. 62(16), 4562-4565
WILKINSON, R. W., ROSS, E. L., POULSOM, R., ILYAS, M., STRAUB, J., SNARY, D., BODMER, W. F. and MATHER, S. J., 2001. Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors Proceedings of the National Academy of Sciences of the United States of America. 98(18), 10256-10260 WHEELER, J M, KIM, H C, EFSTATHIOU, J A, ILYAS, M, MORTENSEN, N J and BODMER, W F, 2001. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut. 48(3), 367-71 KIM, H C, WHEELER, J M, KIM, J C, ILYAS, M, BECK, N E, KIM, B S, PARK, K C and BODMER, W F, 2000. The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Gut. 47(2), 262-7 LAMLUM, H, PAPADOPOULOU, A, ILYAS, M, ROWAN, A, GILLET, C, HANBY, A, TALBOT, I, BODMER, W and TOMLINSON, I, 2000. APC mutations are sufficient for the growth of early colorectal adenomas. Proceedings of the National Academy of Sciences of the United States of America. 97(5), 2225-8 ROWAN, A J, LAMLUM, H, ILYAS, M, WHEELER, J, STRAUB, J, PAPADOPOULOU, A, BICKNELL, D, BODMER, W F and TOMLINSON, I P, 2000. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proceedings of the National Academy of Sciences of the United States of America. 97(7), 3352-7 ILYAS, M, STRAUB, J, TOMLINSON, I P and BODMER, W F, 1999. Genetic pathways in colorectal and other cancers. European Journal of Cancer. 35(3), 335-51 EFSTATHIOU, J A, LIU, D, WHEELER, J M, KIM, H C, BECK, N E, ILYAS, M, KARAYIANNAKIS, A J, MORTENSEN, N J, KMIOT, W, PLAYFORD, R J, PIGNATELLI, M and BODMER, W F, 1999. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 96(5), 2316-21 ILYAS, M, EFSTATHIOU, J A, STRAUB, J, KIM, H C and BODMER, W F, 1999. Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression. Proceedings of the National Academy of Sciences of the United States of America. 96(6), 3087-91 MANN, B, GELOS, M, SIEDOW, A, HANSKI, M L, GRATCHEV, A, ILYAS, M, BODMER, W F, MOYER, M P, RIECKEN, E O, BUHR, H J and HANSKI, C, 1999. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proceedings of the National Academy of Sciences of the United States of America. 96(4), 1603-8 ILYAS, M, STRAUB, J, TOMLINSON, I P and BODMER, W F, 1999. Genetic pathways in colorectal and other cancers. European Journal of Cancer. 35(14), 1986-2002 DAY, R M, HAO, X, ILYAS, M, DASZAK, P, TALBOT, I C and FORBES, A, 1999. Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence. Virchows Archiv. 434(2), 121-5 LAMLUM, H, ILYAS, M, ROWAN, A, CLARK, S, JOHNSON, V, BELL, J, FRAYLING, I, EFSTATHIOU, J, PACK, K, PAYNE, S, ROYLANCE, R, GORMAN, P, SHEER, D, NEALE, K, PHILLIPS, R, TALBOT, I, BODMER, W and TOMLINSON, I, 1999. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nature Medicine. 5(9), 1071-5 FRAYLING, I M, BECK, N E, ILYAS, M, DOVE-EDWIN, I, GOODMAN, P, PACK, K, BELL, J A, WILLIAMS, C B, HODGSON, S V, THOMAS, H J, TALBOT, I C, BODMER, W F and TOMLINSON, I P, 1998. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proceedings of the National Academy of Sciences of the United States of America. 95(18), 10722-7 TOMLINSON, I, ILYAS, M, JOHNSON, V, DAVIES, A, CLARK, G, TALBOT, I and BODMER, W, 1998. A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer. Journal of Pathology. 184(2), 148-52 HOMFRAY, T F, COTTRELL, S E, ILYAS, M, ROWAN, A, TALBOT, I C, BODMER, W F and TOMLINSON, I P, 1998. Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours. Human Mutation. 11(2), 114-20 ILYAS, M, HAO, X P, WILKINSON, K, TOMLINSON, I P, ABBASI, A M, FORBES, A, BODMER, W F and TALBOT, I C, 1998. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer. Gut. 43(3), 383-7 ILYAS, M, TOMLINSON, I P, HANBY, A, TALBOT, I C and BODMER, W F, 1997. Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut. 40(5), 654-9
TOMLINSON, I, ILYAS, M and NOVELLI, M, 1997. Molecular genetics of colon cancer. Cancer metastasis reviews. 16(1-2), 67-79 ILYAS, M, NOVELLI, M, WILKINSON, K, TOMLINSON, I P, ABBASI, A M, FORBES, A and TALBOT, I C, 1997. Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers. Journal of Clinical Pathology. 50(3), 218-22 HAO, X, TOMLINSON, I, ILYAS, M, PALAZZO, J P and TALBOT, I C, 1997. Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours. Virchows Archiv. 431(3), 167-72 ILYAS, M, TOMLINSON, I P, ROWAN, A, PIGNATELLI, M and BODMER, W F, 1997. Beta-catenin mutations in cell lines established from human colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America. 94(19), 10330-4 HAO, X P, ILYAS, M and TALBOT, I C, 1997. Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence. Pathobiology : journal of immunopathology, molecular and cellular biology. 65(3), 140-5
HAO, X, PALAZZO, J P, ILYAS, M, TOMLINSON, I and TALBOT, I C, 1997. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma. Anticancer research. 17(3C), 2241-7
ILYAS, M, KENDALL, M, JALAL, H, LINTON, C and ROONEY, N, 1996. Changes in Bcl-2 and p53 expression in recurrent B-cell lymphomas. Journal of Pathology. 180(3), 249-53 ILYAS, M. and TOMLINSON, I.P.M., 1996. Genetic pathways in colorectal cancer Histopathology. 28, 389-399 ILYAS M., TOMLINSON, I.P.M., NOVELLI, M., HANBY, A., BODMER, W.F. and TALBOT, I.C., 1996. Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability Journal of Pathology. 179(4), 370-375 ILYAS, M, TOMLINSON, I P, HANBY, A M, YAO, T, BODMER, W F and TALBOT, I C, 1996. Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas. American Journal of Pathology. 149(5), 1719-26
ILYAS, M., READ, A.E., NIEDOBITEK, G., AGATHANGGELOU, A., BARRY, RE. and ROONEY, N., 1995. The natural history of Enteropathy, Intestinal lymphoma and Epstein-Barr virus : a study of 13 cases Journal of Pathology. 177, 115-122 ILYAS, M. and TALBOT, I.C., 1995. p53 in ulcerative colitis : a longitudinal study Gut. 37, 802-805